Senseonics Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Senseonics Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Senseonics Holdings Inc SENS.OQ reported a quarterly adjusted loss of 63 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -40 cents. The mean expectation of seven analysts for the quarter was for a loss of 62 cents per share. Wall Street expected results to range from -73 cents to -50 cents per share.
Revenue rose 90.6% to $12.68 million from a year ago; analysts expected $12.87 million.
Senseonics Holdings Inc's reported EPS for the quarter was a loss of 63 cents.
The company reported a quarterly loss of $36.71 million.
Senseonics Holdings Inc shares had fallen by 8.8% this quarter and lost 6.2% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 6.9% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy," 2 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."
Wall Street's median 12-month price target for Senseonics Holdings Inc is $14.00, about 63% above its last closing price of $5.18
This summary was machine generated from LSEG data August 6 at 09:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | -0.62 | -0.63 | Missed |
Mar. 31 2026 | -0.68 | -0.71 | Missed |
Dec. 31 2025 | -0.43 | -0.47 | Missed |
Sep. 30 2025 | -0.28 | -0.43 | Missed |
Recent news on Senseonics Holdings
See all newsDiabetes device firm Beta Bionics jumps after boosted $150 mln equity raise
Diabetes device firm Beta Bionics falls on $150 mln equity raise
Diabetes device firm Beta Bionics slides on $125 mln stock offering plans
Senseonics Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Senseonics Q2 revenue jumps, raises 2026 outlook